United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 1, 2026

On Oct 1, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$564.95 for US$4.69M under a trading plan, leaving 45,172 shares. Filed Oct 1, 2026 (Form 4).

Sold
8,300 shares
Price
US$564.95 average (US$558.30 to US$573.15)
Value
US$4.69M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockOption exercise8,300US$146.0353,472Direct
Oct 1, 2026Common StockSale880US$558.3052,592Direct
Oct 1, 2026Common StockSale1,480US$560.1951,112Direct
Oct 1, 2026Common StockSale780US$561.8750,332Direct
Oct 1, 2026Common StockSale1,480US$563.0948,852Direct
Oct 1, 2026Common StockSale400US$566.4148,452Direct
Oct 1, 2026Common StockSale720US$567.7647,732Direct
Oct 1, 2026Common StockSale739US$569.1546,993Direct
Oct 1, 2026Common StockSale838US$570.9046,155Direct
Oct 1, 2026Common StockSale823US$572.2545,332Direct
Oct 1, 2026Common StockSale160US$573.1545,172Direct

Source

View original at SEC

Related